baber/WOPTO huggingface dataset:
Patent NZ-514461-A (NZ)
Title: Truss jigging system
Inventor: TADICH JOHN
IPC: B27F7/15
Filed: 2000-03-28
Abstract: A truss jigging system has tools (19) moveable in a channel (14) to different locations on an assembly table (10) and which can be readily interchanged.  The tools (19) are capable of snap locking engagement with a carriage (100) mounted in the table channels (14).  A resilient component support (150) on the carriage (100) supports components of the truss (20) in a position above the top of the assembly table (10).  The component support (150) deforms when a downward force is applied by a press for driving connector plates (C) into the components so that the component engages the table (10).
Patent NZ-516058-A (NZ)
Title: Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them
Inventor: PEYMAN ANUSCHIRWAN
IPC: C07D473/34
Filed: 2000-06-26
Abstract: Naphthyridine derivatives of the formula I, in which B, G, Z, X, Y, r, s and t have the meanings indicated in the claims.  These compounds are vitronectin receptor antagonists and inhibitors of cell adhesion and are suitable for the therapy and prophylaxis of illnesses which are based on the interaction between vitronectin receptors and their ligands in cell-cell or cell-matrix interaction processes or which can be prevented, alleviated or cured by influencing such interactions.  For example, they can be applied for inhibiting bone resorption by osteoclasts and thus for treating and preventing osteoporosis, or for inhibiting undesired angiogenesis or proliferation of cells of the vascular smooth musculature.  Also described are processes for the preparation of compounds of the formula I, their use as active ingredients in pharmaceuticals, and pharmaceutical compositions comprising them.
Patent NZ-516423-A (NZ)
Title: Bolus containing an alloy of zinc, magnesium, copper, selenium and cobalt for prevention of facial eczema, foot rot and hypomagnesaemia in livestock
Inventor: WHITEHEAD DEREK JAMES
IPC: A61K33/24
Filed: 2002-01-04
Abstract: Described is a metal alloy comprising, by weight of the total weight of the alloy: a) 50 to 70% of zinc; b) 30 to 45% of magnesium and c) 0.6 to 5% of copper and a bolus comprising such an alloy, as well as a method of treatment of facial eczema using the alloy.
Patent NZ-519069-A (NZ)
Title: Transdermal therapeutic systems having improved stability and their production
Inventor: MULLER WALTER
IPC: A61K47/06
Filed: 2000-11-24
Abstract: A transdermal therapeutic system (TTS) wherein the formation of oxidative degradation products is reduced by at least one active ingredient that is contained in the system and can be oxidised by hydroperoxides during storage of the TTS; and a method for producing a transdermal therapeutic system of this type is disclosed. This system is characterised in that the maximum sum of the peroxide numbers (POZ), exhibited by the constituent parts of the formulation which contain the active ingredient(s) prescribed by the recipe for the TTS is 20.
Patent NZ-521946-A (NZ)
Title: G-protein coupled receptors
Inventor: POWERS SCOTT
IPC: A61K45/00
Filed: 2001-03-13
Abstract: The application provides isolated nucleic acid and amino acid sequences of four novel G-protein coupled receptors that are amplified in breast cancer cells, antibodies to such receptors, methods of detecting such nucleic acids and receptors, and methods of screening for modulators of G-protein coupled receptors.
Patent NZ-531229-A (NZ)
Title: Viral polymerase inhibitors
Inventor: BEAULIEU PIERRE LOUIS
IPC: C07D491/02
Filed: 2002-07-18
Abstract: Disclosed is an isomer, enantiomer, diastereoisomer, or tautomer of a compound, represented by formula (II) or (III) wherein: A is O, S or NR1 where R1 is defined, B is NR3 , R2 and R3 are independently defined, K is N or CR4 where R4 is defined, L is N or CR5 where R5 is defined the same as R4 M is N or CR7 where R7 is defined the same as R4, and Z is N(R6a)R6 where R6a and R6 are as defined. The compounds are disclosed for use as inhibitors of RNA dependent RNA polymerase activity of the enzyme NS5B, encoded by hepatitis C virus (HCV) thus treating or preventing HCV infection.
Patent NZ-533596-A (NZ)
Title: Deuterated substituted dihydrofuranones and medicaments containing these compounds
Inventor: ALKEN RUDOLF-GIESBERT
IPC: A61K31/365
Filed: 2002-12-11
Abstract: Deuterated substituted dihydrofuranones of Formula (I), wherein, R1 is methyl or partially or completely deuterated methyl, R2, independent of one another, indicates H or D, R3, independent of one another, is H or D, R4, independent of one another, indicates H or D, and wherein at least one of the groups R1 to R4 is D or contains D.
Patent NZ-533667-A (NZ)
Title: Use of N-(indolecarbonyl)piperazine derivatives for treating obesity
Inventor: VAN AMSTERDAM CHRISTOPH
IPC: A61K/
Filed: 2002-10-28
Abstract: Disclosed is the use of compounds of formula I for the manufacture of medicaments for the treatment of obesity, wherein: R1 is optionally substituted phenyl or naphthyl, or is Het1, R2 and R3 are independently halogen, A, OA, OH or CN, R4 and R5 are independently H, CN, acyl, halogen, A, OA or OH, CONH2, CONHA or CONA2, or R4 and R5 are alkylene, A is alkyl, and the indole ring may be replaced by an isatin unit.
Patent NZ-535307-A (NZ)
Title: Fungicidal mixtures comprising prothioconazole and boscalid
Inventor: AMMERMANN EBERHARD
IPC: B60Q1/50
Filed: 2003-03-19
Abstract: Disclosed is a fungicidal mixture, comprising 2-[2-(1-chlorocyclopropyl)-3-(2-chlorophenyl)-2-hydroxypropyl]-2,4-dihydro-[1,2,4]-triazole-3-thione (prothioconazole) of the formula (I) and at least one further fungicidal compound consisting of a boscalid of formula (II) wherein the weight ratio of prothioconazole of the formula (I) to the respective fungicide of formula (II) is from 20:1 to 1:20.
Patent NZ-536728-A (NZ)
Title: Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
Inventor: HATAYAMA AKIRA
IPC: C07D417/12
Filed: 2003-04-24
Abstract: Diketohydrazine derivatives represented by the following general formula (I) and pharmaceutically acceptable salts thereof that have a cysteine protease inhibitory activity are disclosed wherein the variables are as defined in the specification. Because of having a cysteine protease inhibitory activity, these compounds are useful as remedies for inflammatory diseases, immune diseases, ischemic diseases, respiratory diseases, circulatory diseases, blood diseases, nerve diseases, liver/biliary duct diseases, bone/joint diseases, metabolic diseases and so on. Because of having an elastase inhibitory activity, these compounds are also useful as remedies for COPD (chronic obstructive pulmonary disease).
Patent NZ-539079-A (NZ)
Title: Cannabinoid receptor ligands useful for the management of pain
Inventor: PAGE DANIEL
IPC: C07D401/14
Filed: 2003-10-15
Abstract: Cannabinoid receptor ligands of formula (I) wherein RF1, RF2, Z, R1, R2, Ar, X and Y are as defined in the specification as well as salts and pharmaceutical compositions including the compounds were prepared. These compounds are useful in therapy, in particular in the management of pain.
Patent NZ-540995-A (NZ)
Title: Self-sealing male luer connector with biased valve plug for an intravenous drip
Inventor: PHILLIPS JOHN C
IPC: A61M39/26
Filed: 2003-12-19
Abstract: A self-sealing male Luer connector for connection with a female Luer conector. The male Luer connector includes a housing having a distally-projecting tubular male body and a surrounding cuff interconnected by a proximal wall in which is formed at least one activation opening. A valve plug is slidably installed within the housing and formed with a distal end configured to sealingly engage the distal end of the male body's interior flow passage and with at least one activation arm at its proximal end configured to extend through the activation opening into the cavity formed between the body and the cuff. An elastomeric device is sealingly configured within the activation opening about the activation arm to secure the valve plug in position and bias it distally. The proximal end of the male Luer connector may be configured as a conventional female connector, a blood collection device, or other such device.
Patent NZ-552096-A (NZ)
Title: Veterinary formulation
Inventor: RAZZAK MAJID HAMEED ABDUL
Filed: 2006-12-15
Abstract: Disclosed is a formulation of cromazine in a solvent system of water and polyethylene glycol, wherein the polyethylene glycol is at least 30% v/v, and the majority of the ployethylene glycols have a molecular weight between 200 and 35,000. Also disclosed is the use of this formulation to treat ectoparasites, such as fly strike in animals. Also disclosed is a method of making the formulation.
Patent NZ-553514-A (NZ)
Title: Lock ring system for an electrical connector or appliance
Inventor: WICKENS IAIN MICHAEL
Filed: 2007-02-27
Abstract: An electrical connector or appliance that comprises a body part of the electrical connector or appliance, and which includes a cord aperture through which a cord enters the connector or appliance, is disclosed. A locking ring is engagable on the body so that a passage through the locking ring aligns with the cord aperture. The locking ring comprises two connected parts that are rotatable relative to one another, and about the passage through the locking ring. A locking means is also provided, which in one relative rotational position of the locking ring parts allows rotational movement of the locking ring on the body and in another relative rotational position of the locking ring parts engages the body to inhibit rotation of the locking ring on the body.
Patent NZ-554232-A (NZ)
Title: Phosphoindoles as HIV inhibitors
Inventor: STORER RICHARD
IPC: A61K31/675
Filed: 2005-09-16
Abstract: Disclosed is a compound of Formula (A) or a pharmaceutically acceptable salt, N-oxide, quaternary amine, stereochemical isomer or tautomer thereof wherein X us a substituted or unsubstituted phenyl; Y is O-alkyl, W is O; S; NH; N-N(R2)(R2); N-OH; or N-O-alkyl; R1, R4', R6', and R7' are each H; Z is caboxamide and wherein the rest of the substituents are disclosed within the specification. Also disclosed is the use of a compound of Formula (A) in the manufacture of a medicament for use for the treatment or prophylaxis of an HIV-infection in a host.
Patent NZ-554638-A (NZ)
Title: Dimple marking of corrugated iron sheet for end alignment
Inventor: WEE ROBERT
Filed: 2007-04-20
Abstract: An apparatus for marking a longitudinal strip of material (14) is disclosed. The longitudinal strip of material (14) is marked along a leading or trailing edge (22). The apparatus includes a means of cutting said longitudinal strip of material to thereby form the leading or trailing edge (22) and marking means adapted to form at least two dimples (12) a predetermined distance inwards of said leading or trailing edge (22). The at least two dimples (12) are disposed on either side of the material's (14) central longitudinal axis.
Patent NZ-555936-A (NZ)
Title: Vertical axis turbine having a movable mass connected to each turbine blade
Inventor: LUETHI MATTHEW
IPC: F03D3/00
Filed: 2005-11-23
Abstract: A turbine is disclosed. The turbine comprises a plurality of turbine blades arranged in such a way about a substantially vertical central axis so as to rotate together about the central axis. Each turbine blade has an outer edge and an inner edge and is pivotally mounted near the outer edge about an axis substantially parallel to the central axis. A biasing means, which biases the inner edge of each turbine blade towards the central axis is provided. When the turbine blades are placed in a fluid flow they rotate together about the central axis and as their speed of rotation increases, they pivot about their mountings against the bias of the biasing means and into a more circumferential orientation about the central axis. The biasing means further comprises a mass positioned substantially on the central axis and axially movable with respect thereto. The mass is connected with each turbine blade where the turbine is adapted so that an increase the speed of rotation of the turbine causes the turbine blades to pivot about their mountings and lift the mass along the central axis.
Patent NZ-556497-A (NZ)
Title: Methods for QT interval control using styramate derivatives
Inventor: NOVAK GERALD
IPC: A61K31/27
Filed: 2006-01-11
Abstract: Disclosed is the use of styramate derivatives of formula (I) or formula (II) in the preparation of a medicament for treating or preventing Long QT syndrome, acquired Long QT syndrome, Torsade de Pointes, ventricular fibrillation or ventricular flutter.
Patent NZ-561652-A (NZ)
Title: Pulp and paper having increased brightness
Inventor: NGUYEN XUAN TRUONG
IPC: D21C9/00
Filed: 2006-02-21
Abstract: The present disclosure relates to a method of increasing the brightness of pulp, pulp made from such methods and methods of using such pulp.
Patent NZ-563543-A (NZ)
Title: Fencing system
Inventor: GREEN JULIAN PAUL WATSON
IPC: E04F11/18
Filed: 2007-11-20
Abstract: An adjustable modular fencing system includes rails 23 with longitudinally extending internal passageways, upright pickets 63 to be connected to the rails, and an elongate locking members 67 each configured to fit within the internal passageway of the rails and to pass through an opening or channel 71 in each picket to secure the picket to the rail without using a through fastening. The locking member and the opening or channel in each picket is configured to allow the pickets to be connected to the rails at a range of angles so that the rails, pickets and locking members cooperate together to ensure that they are held snugly abutting together at any of the angles and to prevent vertical and horizontal movement between the rails and the pickets whilst permitting the variation in the angle.
Patent NZ-576770-A (NZ)
Title: Apparatus and method for use in handling an elongate member
Inventor: CRAWFORD ALEXANDER CHARLES
IPC: E21B19/22
Filed: 2007-10-04
Abstract: Disclosed is an apparatus for use in handling an elongate member, comprising a support line extending between first and second points; a first winch mechanism at the first point for paying out and recovering the support line; a first wrapping device at the first point for rotating one of the elongate member and the support line around the other as they are paid out to wrap the two together, and to unwrap them from one another as they are recovered; a second winch mechanism at the second point, for recovering and paying out the support line; and a second wrapping device at the second point for rotating one of the elongate member and the support line around the other to unwrap them from the one another as they are recovered, and to wrap them together as they are paid out. Also disclosed is a method of handling an elongate member between first and second points that are spaced apart from one other, comprising: paying out a support line between the two points; paying out an elongate member between the two points; wrapping one of the support line and the elongate member around the other as they are being paid out from the first point; unwrapping the support line and the elongate member from one another as they are recovered at the second point. The apparatus and method are useful in raising and lowering a load, towing, and handling service cables, tubes, pipes, hoses or other elongate lines that are connected between two points. A preferred embodiment is described for the subsea deployment of wireline and the deployment of signal and power cables to subsea wells.
Patent NZ-582810-A (NZ)
Title: Novel herbicides
Inventor: TYTE MELLONEY
IPC: A01N43/02
Filed: 2008-08-07
Abstract: Disclosed are tricyclic bridged cyclopentanedione derivatives represented by general formula (I). An example of a compound of formula (I) includes (1RS,2SR,6RS,7SR)-4-(3,5-dimethylbiphenyl-4-yl)-5-oxo-10-oxa-tricyclo[5.2.1.02.6]dec-3-en-3-yl-2,2-dimethylpropionate. The compounds are used to control grasses and weeds in crops.
Patent NZ-585418-A (NZ)
Title: Encoding method using low-density parity check matrix
Inventor: YOKOKAWA TAKASHI
IPC: H03M13/19
Filed: 2008-11-25
Abstract: 585418 Disclosed is a data processing apparatus for encoding using a Low-Density Parity Check (LDPC) code. Code bits of an LDPC code having a code length of N bits are written in a column direction of storage means for storing the code bits in a row direction and the column direction. m bits of the code bits of the LDPC code read out in the row direction are set as one symbol. The storage means stores mb bits in the row direction and stores N/(mb) bits in the column direction, where b is a predetermined positive integer. The code bits of the LDPC code are written in the column direction of the storage means and read out in the row direction. The data processing apparatus includes replacement means for replacing, where the mb code bits read out in the row direction of the storage means set as b symbols, the mb code bits such that the code bits after the replacement form the symbol bits representative of the symbols. The LDPC code is an LDPC code which has a code length N of 64,800 and has an encoding rate of 2/3. The m bits are 8 bits and the integer b is 2. The 8 code bits are mapped as one symbol to ones of 256 signal points prescribed by the 256QAM modulation scheme. The storage means has 16 columns for storing 8 × 2 bits in the row direction and 64,800/(8 × 2) bits in the column direction.
Patent NZ-585853-A (NZ)
Title: Degreasing all purpose cleaning compositions and methods
Inventor: YIANAKOPOULOS GEORGES
IPC: C11D1/83
Filed: 2007-12-18
Abstract: Disclosed herein is a cleaning composition comprising: (i) 0.01 to 15% of an anionic surfactant; (ii) 0.01 to 10% of a nonionic surfactant; (iii) 0.01 to 10% of an amine oxide; the amine oxide being chosen from amine oxides having the given formula, wherein R1 is an alkyl, 2-hydroxyalkyl, 3-hydroxyalkyl, or 3-alkoxy-2-hydroxypropyl radical in which the alkyl and alkoxy each independently contain from 8 to 18 carbon atoms; andR2 and R3 are each independently methyl, ethyl, propyl, isopropyl, 2-hydroxyethyl, 2-hydroxypropyl, or 3-hydroxypropyl; and n is 0 to 10; or wherein the amine oxide is a lauryl/myristyl amido propyl amine oxide; (iv) 0.01 to 10% of a sequestering agent chosen from phosphonic acids having the formulae: R1N[CH2PO3Na2]2 or R1C(PO3Na2)OH wherein R1 is -[(lower)alkylene]N[CH2PO3Na2]2 or a third CH2PO3Na2 moiety, and R2 is C1-C6 alkyl; a low molecular weight phosphonopolycarboxylic acid having about 2 to about 4 carboxylic acid moieties and about 1-3 phosphonic acid groups; 1-phosphono-1-methylsuccinic acid; phosphonosuccinic acid; 2-phosphonobutane-1,2,4-tricarboxylic acid; 1-hydroxyethylidene-1,1-diphosphonic acid (CH3C(PO3Na2)2OH); a amino [tri(methylenephosphonic acid)] (N[CH2PO3Na2]3); ethylenediamine [tetra(methylene-phosphonic acid)]; and 2-phosphonobutane-1,2,4- tricarboxylic, and salts thereof; (v) 0.01 to 10% of a glycol solvent; and (vi) water. Also disclosed is a method for making a detergent comprising the above composition and a method of cleaning a surface comprising contacting the surface with the cleaning composition disclosed herein.
Patent NZ-586909-A (NZ)
Title: Ykl-40 as a general marker for non-specific disease
Inventor: JOHANSEN JULIA
IPC: G01N33/68
Filed: 2009-01-22
Abstract: Disclosed is a method of diagnosing the presence of a non-specific disease or disorder in a subject, wherein a determined level of YKL-40 above a reference level indicates the presence of a non-specific disease or disorder.
Patent NZ-589019-A (NZ)
Title: 3, 4 - substituted piperidine derivatives as renin inhibitors
Inventor: CHEN AUSTIN CHIH-YU
IPC: A61K31/4545
Filed: 2009-05-04
Abstract: Disclosed are trans-4-(2-oxo-1,2-dihydro-pyridin-4-yl)-3-piperidinecarboxamide derivatives as represented by the general formula (I), wherein the substituents are as defined in the specification. Representative compounds include trans-N-[2-chloro-3,5-bis(3-methoxypropyl)benzyl]-N-cyclopropyl-4-(1-methyl-2-oxo-1,2-dihydro-pyridin-4-yl)-3-piperidinecarboxamide, trans-N-{ 3-bromo-5-[3-(difluoromethoxy)propyl]-4-methylbenzyl} -N-cyclopropyl-4-(1-methyl-2-oxo-1,2-dihydro-4-pyridinyl)-3-piperidinecarboxamide, trans-N-({ 3-bromo-4-methyl-5-[3-(methyloxy)propyl]phenyl} methyl)-N-cyclopropyl-4-(1-methyl-2-oxo-1,2-dihydro-4-pyridinyl)-3-piperidinecarboxamide, trans-N-Cyclopropyl-N-( { 2,3-dimethyl-5-[3-(methyloxy)propyl]phenyl} methyl)-4-(1-methyl-2-oxo-1,2-dihydro-4-pyridinyl)-3-piperidinecarboxamide, trans-N-Cyclopropyl-N-({ 4-fluoro-1-[(3-fluorophenyl)methyl]-1H-indol-3 -yl]methyl} -4-(1-methyl-2-oxo-1,2-dihydro-4-pyridinyl)-3-piperidinecarboxamide and trans-N-cyclopropyl-N-({ 2,3-dichloro-5-[3-(methyloxy)propyl] phenyl} methyl)-4-(1-methyl-2-oxo-1,2-dihydro-4-pyridinyl)-3-piperidinecarboxamide. Further disclosed is a pharmaceutical composition which comprises an effective amount of a compound as defined above, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, for the treatment or prophylaxis of diseases which are related to hypertension, congestive heart failure, pulmonary hypertension, renal insufficiency, renal ischemia, renal failure, renal fibrosis, cardiac insufficiency, cardiac hypertrophy, cardiac fibrosis, myocardial ischemia, cardiomyopathy, glomerulonephritis, renal colic, complications resulting from diabetes, glaucoma, elevated intra-ocular pressure, atherosclerosis, restenosis post angioplasty, complications following vascular or cardiac surgery, erectile dysfunction, hyperaldosteronism, lung fibrosis, scleroderma, anxiety, cognitive disorders, complications of treatments with immunosuppressive agents, and other diseases known to be related to the renin-angiotensin system.
Patent NZ-591950-A (NZ)
Title: Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition
Inventor: BECK MICHAEL
IPC: A61K39/02
Filed: 2009-10-22
Abstract: Disclosed are combination vaccines and/or the combined use of immunogenic compositions for the treatment and/or prophylaxis of cattle against microbiological infections, wherein the infections are caused by M. bovis and at least one further cattle relevant pathogen. The combination vaccine as described herein comprises at least one M. bovis antigen, preferably the attenuated, avirulent M. bovis produced by passage greater than fifty (50) times and one or more further immunologically active components effective for the treatment and/or prophylaxis of infections caused by a further pathogen of cattle.
Patent NZ-594799-A (NZ)
Title: Quality of service for device assisted services
Inventor: RALEIGH GREGORY G
IPC: H04W4/50
Filed: 2010-01-27
Abstract: A wireless device and a process for implementing a service policy on a device are disclsoed. The device comprises means for obtaining a quality of service (OoS) activity map, of an application identifier to a OoS policy, from a user interface or a network interface, means for identifying a device service usage in association with the application identifier; means for applying the OoS policy from the OoS activity map to the device service usage and means for processing the device service usage in accordance with the OoS policy. The OoS policy is determined at least in part by an access state qualifier and the access state qualifier characterizing an aspect of access network resources. A OoS service activity, including the device service usage, falls within a class of activities associated with the application identifier and governed by the OoS policy;